Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma (Q65346130)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma |
clinical trial |
Statements
A Phase 2 Study of GPNMB-Targeted Antibody-Drug Conjugate, CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE; NSC# 763737), in Recurrent or Refractory Osteosarcoma (English)
0 references
16 February 2016
0 references
30 June 2017
0 references
22
0 references
12 year
0 references
49 year
0 references